default author photo

Marc Peeters

University of Antwerp - Multidisciplinary Oncologic Centre Antwerp (MOCA)

Antwerp University Hospital

Drie Eikenstraat 655

Edegem, 2650

Belgium

University of Antwerp - Center for Oncological Research (CORE)

Drie Eikenstraat 655

Edegem, 2650

Belgium

SCHOLARLY PAPERS

3

DOWNLOADS

390

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Antibody Response after BNT162B2 COVID-19 mRNA Vaccination in Cancer Patients Under Anti-Neoplastic Treatment

Number of pages: 28 Posted: 16 Jun 2021
University of Antwerp - Multidisciplinary Oncologic Centre Antwerp (MOCA), University of Antwerp, University of Antwerp, University of Antwerp, Sciensano, University of Antwerp - Antwerp University Hospital (UZA), University of Antwerp, University of Antwerp, University of Antwerp, University of Antwerp - Antwerp University Hospital (UZA), Université Libre de Bruxelles (ULB) - ULB Center for Research in Immunology (U-CRI), Sciensano, University of Antwerp - Department of Clinical Sciences, AZ Delta General Hospital - AZ Delta Medical Laboratories, Sciensano, University of Antwerp, Sciensano, University of Antwerp, Sciensano, University of Antwerp and University of Antwerp
Downloads 187 (405,402)
Citation 1

Abstract:

Loading...

2.

Expression of SARS-CoV-2 Related Surface Proteins in Non-Small Cell Lung Cancer Patients and the Influence of Standard of Care Therapy

Number of pages: 29 Posted: 25 Feb 2022
University of Antwerp - Center for Oncological Research (CORE), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Antwerp - Antwerp University Hospital (UZA), affiliation not provided to SSRN, University Hospital Antwerp, University of Antwerp, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Antwerp - Multidisciplinary Oncologic Centre Antwerp (MOCA) and affiliation not provided to SSRN
Downloads 142 (518,102)

Abstract:

Loading...

SARS-CoV-2, ACE2, Lung cancer

3.

Treatment and Survival Outcomes by Age Following Second-Line Therapy for Metastatic CRC (mCRC): Analysis of 13,149 Patients from the ARCAD Clinical Trials Program

Number of pages: 28 Posted: 08 Feb 2021
Harvard University - Dana-Farber Cancer Institute, Mayo Clinic - Department of Health Science Research, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Monash University, Cardiff University and Velindre Cancer Centre, West Cancer Center and Research Institute, Ospedale San Martino - Medical Oncology Unit, KU Leuven, West Virginia University Cancer Institute and the Mary Babb Randolph Cancer Center, University of Antwerp - Multidisciplinary Oncologic Centre Antwerp (MOCA), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, University of Leeds - Institute of Oncology, Memorial Sloan Kettering Cancer Center, University of Pennsylvania Perelman School of Medicine - Abramson Cancer Center, Instituto CUF de Oncologia, Pfizer, Inc. - Global Product Development, University Medical Center Utrecht - Department of Medical Oncology, Martin Luther University, Mayo Clinic - Department of Oncology, University of São Paulo (USP) - Instituto do Cancer do Estado de Sao Paulo, University of Sydney Medical School, University of Pisa - Department of Oncology, University General Hospital of Heraklion - Department of Medical Oncology, Universitatsklinikum Hamburg-Eppendorf, LMU Munich - Department of Hematology/Oncology, National Cancer Center Hospital East, Institut Franco-Britannique - Department of Medical Oncology, Institut Franco-Britannique - Department of Medical Oncology, Mayo Clinic - Department of Health Science Research and NIHR Clinical Research Network, Leeds
Downloads 61 (951,658)

Abstract:

Loading...